← Current compounder rows

Current NDC auxiliary source row compounder:2445

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source
ndc_compounder_zip
Product Ndc Raw
79559-4064
Product Ndc
79559-4064
Product Ndc Digits
795594064
Product Type Name
HUMAN COMPOUNDED DRUG
Proprietary Name
S-TA064
Proprietary Name Suffix
[empty]
Nonproprietary Name
S-TA064
Dosage Form Name
PELLET, IMPLANTABLE
Route Name
SUBCUTANEOUS
Marketing Category Name
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name
F. H. Investments. Inc. DBA Asteria Health
Establishment Name
F. H. Investments. Inc. DBA Asteria Health
Establishment Fei
[empty]
Substance Name
TESTOSTERONE; ANASTROZOLE
Active Ingredients Info
60 mg/64 mg; 4 mg/64 mg
History Active Ingredients Raw
TESTOSTERONE; ANASTROZOLE
History Active Ingredients Info Raw
60 mg/64 mg; 4 mg/64 mg
History Dosage Raw
PELLET, IMPLANTABLE
Dea Schedule
CIII
Package Ndc Raw
79559-4064-1
Package Ndc
79559-4064-1
Package Ndc Digits
7955940641
Package Ndc11
79559406401
Package Description
64 mg in 1 VIAL, PLASTIC (79559-4064-1)
Reporting Period Raw
2024-2
Reporting Period
2024-2
Normalization Status
valid
Source Url
https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive
compounders_ndc_directory.zip
Source File
compounders_ndc_directory.txt
Source Date
2026-09-18
Source Last Modified
Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256
222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256
f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id
compounder:2445
Source Row Number
2445
Source Row Hash
e42e4a2758f052c0ef500777f7bc2a86f8ec62238624561158dff7541850c34d
Import Run Id
20261119T172627Z
Loaded At
2026-11-19 17:42:45

Exact raw FDA source fields#

{
    "ROUTENAME": "SUBCUTANEOUS",
    "PRODUCTNDC": "79559-4064",
    "DEASCHEDULE": "CIII",
    "LABELERNAME": "F. H. Investments. Inc. DBA Asteria Health",
    "SUBSTANCENAME": "TESTOSTERONE; ANASTROZOLE",
    "DOSAGEFORMNAME": "PELLET, IMPLANTABLE",
    "NDCPACKAGECODE": "79559-4064-1",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "S-TA064",
    "REPORTINGPERIOD": "2024-2",
    "NONPROPRIETARYNAME": "S-TA064",
    "PACKAGEDESCRIPTION": "64 mg in 1 VIAL, PLASTIC (79559-4064-1) ",
    "ACTIVEINGREDIENTSINFO": "60 mg/64 mg; 4 mg/64 mg",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset
compounder
Record Source
ndc_compounder_zip
Source Record Id
compounder:2445
Source Row Number
2445
Status Scope
package
Lookup Ndc
79559-4064-1
Lookup Ndc Digits
7955940641
Product Ndc
79559-4064
Product Ndc Digits
795594064
Package Ndc
79559-4064-1
Package Ndc Digits
7955940641
Package Ndc11
79559406401
Product Id
[empty]
Status Code
COMPOUNDER
Status Label
Outsourcing facility compounded drug report
Reporting Period Raw
2024-2
Reporting Period
2024-2
Source Table
fda_ndc_aux_compounder
Source File
compounders_ndc_directory.txt
Source Date
2026-09-18
Source Row Hash
e42e4a2758f052c0ef500777f7bc2a86f8ec62238624561158dff7541850c34d
Import Run Id
20261119T172627Z
Loaded At
2026-11-19 17:42:45